These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 12768334

  • 1. 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
    Li S, Kurtaran A, Li M, Traub-Weidinger T, Kienast O, Schima W, Angelberger P, Virgolini I, Raderer M, Dudczak R.
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1087-95. PubMed ID: 12768334
    [Abstract] [Full Text] [Related]

  • 2. Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
    Virgolini I, Patri P, Novotny C, Traub T, Leimer M, Füger B, Li SR, Angelberger P, Raderer M, Wogritsch S, Kurtaran A, Kletter K, Dudczak R.
    Ann Oncol; 2001 Aug; 12 Suppl 2():S41-5. PubMed ID: 11762351
    [Abstract] [Full Text] [Related]

  • 3. Comparison of 111In-DOTA-DPhe1-Tyr3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours.
    Rodrigues M, Traub-Weidinger T, Li S, Ibi B, Virgolini I.
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):532-40. PubMed ID: 16491425
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
    Raderer M, Traub T, Formanek M, Virgolini I, Osterreicher C, Fiebiger W, Penz M, Jäger U, Pont J, Chott A, Kurtaran A.
    Br J Cancer; 2001 Nov 16; 85(10):1462-6. PubMed ID: 11720429
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide.
    Putzer D, Kroiss A, Waitz D, Gabriel M, Traub-Weidinger T, Uprimny C, von Guggenberg E, Decristoforo C, Warwitz B, Widmann G, Virgolini IJ.
    Eur J Nucl Med Mol Imaging; 2013 Feb 16; 40(3):364-72. PubMed ID: 23151915
    [Abstract] [Full Text] [Related]

  • 7. Differentiation of low-grade gastric MALT lymphoma and high-grade gastric MALT lymphoma: the clinical value of Ga-67 citrate scintigraphy--a pilot study.
    Hsu CH, Sun SS, Kao CH, Lin CC, Lee CC.
    Cancer Invest; 2002 Feb 16; 20(7-8):939-43. PubMed ID: 12449725
    [Abstract] [Full Text] [Related]

  • 8. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.
    Traub-Weidinger T, Von Guggenberg E, Dobrozemsky G, Kendler D, Eisterer W, Bale R, Putzer D, Gabriel M, Virgolini I.
    Q J Nucl Med Mol Imaging; 2010 Feb 16; 54(1):52-60. PubMed ID: 20168286
    [Abstract] [Full Text] [Related]

  • 9. 111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.
    Traub T, Petkov V, Ofluoglu S, Pangerl T, Raderer M, Fueger BJ, Schima W, Kurtaran A, Dudczak R, Virgolini I.
    J Nucl Med; 2001 Sep 16; 42(9):1309-15. PubMed ID: 11535718
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
    Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R.
    Curr Pharm Des; 2002 Sep 16; 8(20):1781-807. PubMed ID: 12171531
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results.
    Demirci E, Ocak M, Kabasakal L, Araman A, Ozsoy Y, Kanmaz B.
    Nucl Med Commun; 2013 Aug 16; 34(8):727-32. PubMed ID: 23728519
    [Abstract] [Full Text] [Related]

  • 13. Gallium-67 citrate scintigraphy and marginal zone lymphoma of the mucosa-associated lymphoid tissue. Ocular MALT.
    Taşkaya Yaylali O, Suna Kiraç F, Yaylali V, Gündüz K, Düzcan E.
    Hell J Nucl Med; 2007 Aug 16; 10(3):160-3. PubMed ID: 18084656
    [Abstract] [Full Text] [Related]

  • 14. Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinoma.
    Li S, Beheshti M, Peck-Radosavljevic M, Oezer S, Grumbeck E, Schmid M, Hamilton G, Kapiotis S, Dudczak R, Kletter K.
    Liver Int; 2006 Oct 16; 26(8):920-7. PubMed ID: 16953831
    [Abstract] [Full Text] [Related]

  • 15. DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.
    Smith-Jones PM, Bischof C, Leimer M, Gludovacz D, Angelberger P, Pangerl T, Peck-Radosavljevic M, Hamilton G, Kaserer K, Kofler A, Schlangbauer-Wadl H, Traub T, Virgolini I.
    Endocrinology; 1999 Nov 16; 140(11):5136-48. PubMed ID: 10537142
    [Abstract] [Full Text] [Related]

  • 16. Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results.
    Valencak J, Heere-Ress E, Traub-Weidinger T, Raderer M, Schneeberger A, Thalhammer T, Aust S, Hamilton G, Virgolini I, Pehamberger H.
    Melanoma Res; 2005 Dec 16; 15(6):523-9. PubMed ID: 16314738
    [Abstract] [Full Text] [Related]

  • 17. Visualization of esophageal non-Hodgkin's lymphoma with Ga-67 scintigraphy.
    Nishryama Y, Yamamoto Y, Ono Y, Satoh K, Ohkawa M, Yamauchi A, Tanabe M.
    Ann Nucl Med; 1999 Dec 16; 13(6):419-21. PubMed ID: 10656277
    [Abstract] [Full Text] [Related]

  • 18. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
    Virgolini I, Szilvasi I, Kurtaran A, Angelberger P, Raderer M, Havlik E, Vorbeck F, Bischof C, Leimer M, Dorner G, Kletter K, Niederle B, Scheithauer W, Smith-Jones P.
    J Nucl Med; 1998 Nov 16; 39(11):1928-36. PubMed ID: 9829585
    [Abstract] [Full Text] [Related]

  • 19. A comparison of 111In-octreotide and 67Ga scintigraphy in malignant lymphoma.
    Cerulus G, Léonard JP.
    Nucl Med Commun; 1997 Jul 16; 18(7):616-22. PubMed ID: 9342098
    [Abstract] [Full Text] [Related]

  • 20. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Yang CC, Sun SS, Lin CC, Kao CH, Lee CC.
    Anticancer Res; 2001 Jul 16; 21(5):3695-8. PubMed ID: 11848545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.